IMPORTANT WITHDRAWAL NOTICE - AmBisome Liposomal Amphotericin B 50mg Powder for Concentrate for Dispersion for Infusion (HA705) - Minisart® Filter
On 05 February 2021, Gilead Sciences Ltd.
On 05 February 2021, Gilead Sciences Ltd.
On 13 November 2020, WHO listed the nOPV2 vaccine (Bio Farma, Indonesia) for eme
WHO Prequalification Unit - Medicines Assessment Team (PQT/MED) has been in contact with Sanofi regarding the presence of 1-cyclopentyl-4-nitrosopiperazine (CPNP) in their tuberculosis treatment -
Nitrosamine impurities have been identified in rifapentine and rifampicin products.
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Medicine Regulatory Authorities firs
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
The WHO Prequalification Team (PQT) is aware, and monitoring closely, announcements by major regulators regarding the presence of nitrosamine impurities in batches of sartan-related products, piog